Other possible explanations could be that the nature of the TSC1 mutation led to incomplete inactivation of the TSC1/TSC2 complex or other coincident mutations in these tumors such as mutations in TP53 may contribute to different tumor behavior and outcome (Fig 1D). The gene discussed is TSC1; the disease is neoplasm.